Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-2568.02%Return on Equity
VS
Market
Sector
Industry
History
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 3.97M | $ -101.98M | -2568.02% |
| 3/31/2025 | $ 22.94M | $ 14.6M | 63.62% |
| 12/31/2024 | $ 22.15M | $ -37.45M | -169.08% |
| 9/30/2024 | $ 59.62M | $ -16.76M | -28.11% |
| 6/30/2024 | $ 94.45M | $ 17.63M | 18.67% |
| 3/31/2024 | $ 1.04M | $ -128.91M | -12443.34% |
| 12/31/2023 | $ 51.1M | $ -101.17M | -197.98% |
| 9/30/2023 | $ 67.59M | $ -111.14M | -164.42% |
| 6/30/2023 | $ 67.53M | $ -130.71M | -193.54% |
| 3/31/2023 | $ 51.68M | $ -96.21M | -186.18% |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at -60.83%.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average ROE has been -865.1%.
- The median ROE for X4 PHARMACEUTICALS INC during this period was -161.89%
- X4 PHARMACEUTICALS INC reached its highest ROE over the past 5 years at 63.62%.
- The lowest ROE recorded by X4 PHARMACEUTICALS INC in the same timeframe -12443.34%
X4 PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for X4 PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -54.57M ] / Equity [ $ 89.71M ]
(=) ROE [ -60.83% ] XFOR - Return on Equity, Last 5 years
-12443.34%
Minimum
Mar 31, 2024
63.62%
Maximum
Mar 31, 2025
-865.1%
Average
-161.89%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |